Mirum Pharmaceuticals Inc (MIRM)
43.48
-0.21
(-0.48%)
USD |
NASDAQ |
Nov 21, 16:00
43.48
0.00 (0.00%)
After-Hours: 17:48
Mirum Pharmaceuticals Price to Book Value: 8.996 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 9.039 |
| November 19, 2024 | 8.708 |
| November 18, 2024 | 8.570 |
| November 15, 2024 | 9.207 |
| November 14, 2024 | 9.571 |
| November 13, 2024 | 9.087 |
| November 12, 2024 | 8.748 |
| November 11, 2024 | 8.609 |
| November 08, 2024 | 8.690 |
| November 07, 2024 | 8.493 |
| November 06, 2024 | 8.495 |
| November 05, 2024 | 8.418 |
| November 04, 2024 | 8.362 |
| November 01, 2024 | 8.352 |
| October 31, 2024 | 7.951 |
| October 30, 2024 | 8.10 |
| October 29, 2024 | 8.075 |
| October 28, 2024 | 8.174 |
| October 25, 2024 | 8.04 |
| October 24, 2024 | 8.137 |
| October 23, 2024 | 7.943 |
| October 22, 2024 | 8.203 |
| October 21, 2024 | 8.135 |
| October 18, 2024 | 8.158 |
| October 17, 2024 | 8.129 |
| Date | Value |
|---|---|
| October 16, 2024 | 8.224 |
| October 15, 2024 | 8.210 |
| October 14, 2024 | 8.222 |
| October 11, 2024 | 8.292 |
| October 10, 2024 | 7.955 |
| October 09, 2024 | 7.825 |
| October 08, 2024 | 8.044 |
| October 07, 2024 | 8.011 |
| October 04, 2024 | 8.116 |
| October 03, 2024 | 8.189 |
| October 02, 2024 | 8.578 |
| October 01, 2024 | 8.294 |
| September 30, 2024 | 8.063 |
| September 27, 2024 | 8.094 |
| September 26, 2024 | 8.063 |
| September 25, 2024 | 8.123 |
| September 24, 2024 | 8.121 |
| September 23, 2024 | 8.111 |
| September 20, 2024 | 8.117 |
| September 19, 2024 | 8.198 |
| September 18, 2024 | 7.896 |
| September 17, 2024 | 8.394 |
| September 16, 2024 | 8.421 |
| September 13, 2024 | 8.567 |
| September 12, 2024 | 8.569 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.093
Minimum
Nov 25 2019
19.35
Maximum
Sep 15 2023
5.835
Average
5.180
Median
Aug 27 2021
Price to Book Value Benchmarks
| Arcutis Biotherapeutics Inc | 7.652 |
| Cytokinetics Inc | -- |
| Amicus Therapeutics Inc | 15.85 |
| MannKind Corp | -- |
| TG Therapeutics Inc | 27.95 |
Price to Book Value Related Metrics
| PS Ratio | 6.676 |
| Price | 43.48 |
| Earnings Yield | -4.76% |
| Market Cap | 2.087B |